Pulmonx Corporation (LUNG) vs Outset Medical, Inc. (OM)

A side-by-side comparison of Pulmonx Corporation and Outset Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LUNG vs OM

growth of $100 · dividends reinvested · last 6y
LUNG -95.2% (-39.8%/yr)OM -99.4% (-57.4%/yr)LUNG compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120222023202420252026$5$1
LUNG OM

LUNG vs OM: by the numbers

  • •LUNG is the larger company ($78M vs $76M market cap).
  • •Both run net losses; LUNG's is the smaller (-55.03% vs -63.06% net margin).
  • •LUNG grew revenue faster over the past five years (15.86% vs 8.28% CAGR).

Metrics side by side

Valuation

MetricLUNGOM
P/S ratio0.900.65
P/B ratio2.000.79

Profitability

MetricLUNGOM
Gross margin77.06%41.76%
Operating margin-52.96%-56.06%
Net margin-55.03%-63.06%
ROE-122.76%-77.12%
ROIC-48.39%-33.27%

Growth (annualized)

MetricLUNGOM
Revenue CAGR (5Y)15.86%8.28%
Total return CAGR (5Y)-45.30%-64.47%

Frequently asked

Which has grown faster, LUNG or OM?
Over the past five years, LUNG grew revenue faster — LUNG at a 15.86% CAGR versus OM at 8.28%.
How have LUNG and OM total returns compared?
Over the past 5 years, LUNG delivered -45.30% and OM delivered -64.47% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.